Altuviiio

Indicated For

hemophilia A

About This Medication

# HemAssist Patient Assistance Programs for ALTUVIIIO: How to Get Treatment at Low or No Cost ## About ALTUVIIIO ALTUVIIO (Antihemophilic Factor [Recombinant], Fc-VWF-XTEN Fusion Protein-ehtl) is a prescription medication manufactured by Sanofi for treating hemophilia A. This guide explains how to access financial assistance programs that can help you afford this essential treatment. ## Who Qualifies for Assistance Sanofi's HemAssist program offers multiple financial assistance options designed to help different patient situations: - **Copay Assistance Program**: For patients with commercial insurance who need help paying copays - **Patient Assistance Program**: For uninsured, underinsured, or patients experiencing temporary loss of insurance coverage - **Free Trial Program**: For patients newly prescribed ALTUVIIIO for the first time ## Income Eligibility Sanofi does not publicly disclose specific income thresholds for ALTUVIIIO assistance programs. Income eligibility is determined on a case-by-case basis during the benefits investigation process. The HemAssist team will work directly with you to assess your financial situation and identify programs for which you may qualify. ## Insurance Requirements Insurance eligibility varies by program: | Program | Insurance Type | Eligibility | |---------|---|---| | Copay Assistance | Commercial/Private Insurance | Eligible patients with active coverage | | Patient Assistance | Uninsured/Underinsured | Eligible; NOT available for Medicare, Medicaid, Medigap, VA, DoD, or TRICARE | | Free Trial Program | Commercial or Government Insurance | Eligible for first-time ALTUVIIIO patients; no financial eligibility criteria | **Important Note**: The Patient Assistance Program is not available if you are utilizing state or federally funded health insurance programs such as Medicare (including Medicare Part D), Medicaid, Medigap, VA, DoD, or TRICARE. ## How to Apply ### Step 1: Get a Prescription Your healthcare provider must prescribe ALTUVIIIO. Once you have a valid prescription, you can begin the enrollment process. ### Step 2: Contact HemAssist You can enroll in HemAssist programs by: - Calling the HemAssist team - Completing an enrollment form (available through your healthcare provider or Sanofi's website) - Working with your specialty pharmacy ### Step 3: Benefits Investigation Once HemAssist receives your enrollment form, a dedicated Case Manager will: - Review your health insurance information - Assess your coverage for ALTUVIIIO - Determine which financial assistance programs you may be eligible for - Contact you within 24 hours with next steps ### Step 4: Enrollment Confirmation Your Case Manager will guide you through completing enrollment and explain your specific benefits and any out-of-pocket costs. ## Timeline and Medication Delivery **Free Trial Program**: Patients can receive their first 30-day supply of ALTUVIIIO generally within 24 to 48 hours with a valid prescription. **Other Programs**: Processing timelines vary based on insurance verification and program type. Your Case Manager will provide specific timeline information during enrollment. **Delivery Method**: ALTUVIIIO is dispensed through a specialty pharmacy network. HemAssist coordinates with your specialty pharmacy to ensure medication shipment and delivery. ## Required Documentation While specific documentation requirements are not publicly detailed, typical information needed includes: - Valid prescription from your healthcare provider - Health insurance information (if applicable) - Financial information for income-based programs - Identification and contact information Your Case Manager will inform you of any additional documentation needed during the enrollment process. ## What Happens If Your Application Is Denied If you are denied for a particular program, HemAssist will work with you to identify alternative assistance options. The program is designed to help patients afford treatment, and the team will explore other pathways based on your specific situation. Your Case Manager can discuss: - Alternative financial assistance programs - Insurance appeal options - Other resources available through Sanofi or patient advocacy organizations ## Reauthorization and Ongoing Support Program enrollment is typically valid for one year and is renewable if your circumstances remain the same. HemAssist provides ongoing support throughout your treatment, including: - Periodic check-ins to ensure continued eligibility - Assistance navigating insurance changes - Support with claims and reimbursements - Supplemental infusion training and education - Adherence support to help you stay with your treatment as prescribed ## Additional Support Services Beyond financial assistance, HemAssist provides: - **Education**: Information about hemophilia A and ALTUVIIIO treatment - **Infusion Training**: Supplemental training on how to properly infuse your medication - **Insurance Navigation**: Help understanding your coverage and working with your insurance company - **Treatment Support**: Guidance to help you maintain motivation and build a treatment routine ## Important Disclaimers - These programs are subject to change and may have restrictions not listed here - Eligibility and benefits vary by individual circumstances - Programs are not valid where prohibited by law - Savings vary depending on individual out-of-pocket costs - Insurance plans may attempt to limit the impact of assistance programs; Sanofi may adjust program terms in such situations ## Next Steps If you have been prescribed ALTUVIIIO, contact HemAssist today to learn about your options. A dedicated Case Manager will work with you to verify your insurance coverage and identify the financial assistance programs for which you may be eligible. The goal is to help you access and afford your treatment as efficiently as possible.

Program information last verified: March 30, 2026